activationacuteadamts13adultadultsagingallogeneicamlanemiaantiantibodiesantibodyantigenaplaplasticassessmentassociatedbispecificbleedingbonecancercausescd19celcellcellschemotherapychronicclassicalclinicalcllclonalcmlcnscombinationcovidcytokinediagnoseddiagnosisdiffusediseasedisordersdlbcldonordrivesdualearlyeffectsfactorfailurefirstfixedfollicularfunctiongenegeneticgenomicgermlinegvhdhaploidenticalhcthematologichematopoiesishematopoietichemophiliahighhlhhodgkinhomeostasishschscthumanibrutinibimmuneimmunityimpactinducedinductioninfectioninflammationinhibitioninhibitorinhibitorsinsightsironitpkinaselargelenalidomideleukemialeukemiaslinelonglosslymphoblasticlymphomalymphomasmacrophagemaintenancemalignanciesmalignancymantlemarrowmclmdsmechanismsmicroenvironmentmmmodelmolecularmonoclonalmrdmultiplemutantmutatedmutationsmyelodysplasticmyelofibrosismyeloidmyelomanegativeneoplasmsneutrophilnewlynknovelnpm1obinutuzumabolderoutcomespatientspdpediatricpembrolizumabplateletplateletspluspositivepostpredictionpreventionprimaryprognosticpromotesprophylaxisrapidrealreceptorrefractoryrelapserelapsedrelatedresearchresistanceresponsereviewriskrituximabroleruxolitinibscdseasonseriesseveresicklesignalingspecificstemstratificationstrokesurvivalsyndromesyndromestargetedtargetingtermthalassemiatherapythrombocytopeniathrombosistp53transplanttransplantationtreattreatedtreatmenttrialttptypeusingvaccinationvariantsvenetoclaxvenousversusvexasvtevwfwillebrandworld